Characteristics | Low expression of FDCSP | High expression of FDCSP | p value |
---|---|---|---|
n | 266 | 266 | |
Pathologic T stage, n (%) | 0.006 | ||
T1 | 153 (28.8%) | 119 (22.4%) | |
T2 | 36 (6.8%) | 33 (6.2%) | |
T3 | 74 (13.9%) | 106 (19.9%) | |
T4 | 3 (0.6%) | 8 (1.5%) | |
Histologic grade, n (%) | < 0.001 | ||
G1 | 10 (1.9%) | 4 (0.8%) | |
G2 | 122 (23.3%) | 106 (20.2%) | |
G3 | 109 (20.8%) | 97 (18.5%) | |
G4 | 21 (4%) | 55 (10.5%) | |
Pathologic stage, n (%) | 0.002 | ||
Stage I | 150 (28.4%) | 116 (21.9%) | |
Stage II | 30 (5.7%) | 27 (5.1%) | |
Stage III | 59 (11.2%) | 64 (12.1%) | |
Stage IV | 27 (5.1%) | 56 (10.6%) | |
Pathologic N stage, n (%) | 0.036 | ||
N0 | 125 (48.8%) | 115 (44.9%) | |
N1 | 4 (1.6%) | 12 (4.7%) | |
Pathologic M stage, n (%) | < 0.001 | ||
M0 | 224 (44.8%) | 197 (39.4%) | |
M1 | 24 (4.8%) | 55 (11%) | |
OS event, n (%) | < 0.001 | ||
Alive | 201 (37.8%) | 156 (29.3%) | |
Dead | 65 (12.2%) | 110 (20.7%) | |
Age, n (%) | 0.386 | ||
< = 60 | 137 (25.8%) | 127 (23.9%) | |
> 60 | 129 (24.2%) | 139 (26.1%) | |
Gender, n (%) | 0.318 | ||
Female | 88 (16.5%) | 99 (18.6%) | |
Male | 178 (33.5%) | 167 (31.4%) | |
Laterality, n (%) | 0.830 | ||
Left | 124 (23.4%) | 126 (23.7%) | |
Right | 142 (26.7%) | 139 (26.2%) |